Benzinga | Aug 11, 2021 04:15PM EDT

Prometheus Biosciences Q2 EPS $(0.49) Up From $(5.93) YoY, Sales $326.00K Up From $179.00K YoY

Prometheus Biosciences (NASDAQ:RXDX) reported quarterly losses of $(0.49) per share. This is a 91.74 percent increase over losses of $(5.93) per share from the same period last year. The company reported $326.00 thousand in sales this quarter. This is a 82.12 percent increase over sales of $179.00 thousand the same period last year.